A Phase II, Open-Label, Multicenter Trial to Investigate the Clinical Activity and Safety of Avelumab (MSB0010718C) in Subjects With Merkel Cell Carcinoma
收藏DataCite Commons2026-04-29 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00013047/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
This is a multicenter, international, single-arm, open-label, Phase 2 trial to evaluate the efficacy and safety of avelumab in participants with metastatic Merkel cell carcinoma (MCC).
提供机构：
Vivli
创建时间：
2026-04-29
